You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What are the side effects of lurbinectedin for breast cancer?



Lurbinectedin is a chemotherapy drug that has been recently approved by the FDA for the treatment of metastatic small cell lung cancer [3]. However, there is limited information on its side effects specifically for breast cancer.

According to the drug patent watch website, the most common side effects of Lurbinectedin include fatigue, nausea, vomiting, constipation, decreased appetite, and anemia [1]. In a clinical trial conducted on patients with relapsed small cell lung cancer, the most common side effects observed were myelosuppression (decreased blood cell counts), fatigue, nausea, and decreased appetite [2].

In addition to these common side effects, Lurbinectedin can also cause serious side effects such as myelosuppression, liver toxicity, and respiratory failure [2]. Therefore, patients taking Lurbinectedin should be closely monitored for any signs of these serious side effects.

In conclusion, while there is limited information on the side effects of Lurbinectedin specifically for breast cancer, the most common side effects observed in clinical trials include fatigue, nausea, vomiting, constipation, decreased appetite, and anemia. Patients taking Lurbinectedin should be closely monitored for any signs of serious side effects such as myelosuppression, liver toxicity, and respiratory failure.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165873/
[3] https://www.cancer.org/cancer/types/lung-cancer/treating-small-cell/chemotherapy.html



Follow-up:   patients? How effective is lurbinectedin for breast cancer treatment? Are there any long-term effects of using lurbinectedin? What is the recommended dosage of lurbinectedin for breast cancer patients?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.